Skip to main content
. 2018 Nov 14;14(3):165–169. doi: 10.1159/000490040

Table 1.

General information by the study participants regarding the use of lipotransfer in breast cancer patientsa

1 2 3 4 5 Rating Average
Only method after mastectomy 6 7 5 8 8 3.15

After mastectomy and implant reconstruction 9 15 8 2 0 2.09

After a breast-conserving operation without significant intraglandular volume reconstruction < 25% 3 8 12 7 3 2.97

After a breast-conserving operation with significant intraglandular volume reconstruction > 25% 6 3 7 14 3 3.15

Contour enhancement after autologous tissue reconstruction 10 0 2 2 1 1.93
a

1 = Most frequent; 5 = least frequent.